Neitzel, J; Franzmeier, N; Rubinski, A; Dichgans, M; Brendel, M; Alzheimer’s Disease Neuroimaging Initiative (ADNI), .; Malik, R; Neitzel, J; Franzmeier, N; Rubinski, A; Dichgans, M; Brendel, M; Alzheimer’s Disease Neuroimaging Initiative (ADNI), .; Malik, R; Ewers, M; - view fewer (2021) KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease. Nature Communications , 12 (1) , Article 3825. 10.1038/s41467-021-23755-z.

Preview

Text s41467-021-23755-z.pdf - Published Version Download (1MB) | Preview

Abstract

Klotho-VS heterozygosity (KL-VShet) is associated with reduced risk of Alzheimer's disease (AD). However, whether KL-VShet is associated with lower levels of pathologic tau, i.e., the key AD pathology driving neurodegeneration and cognitive decline, is unknown. Here, we assessed the interaction between KL-VShet and levels of beta-amyloid, a key driver of tau pathology, on the levels of PET-assessed neurofibrillary tau in 551 controls and patients across the AD continuum. KL-VShet showed lower cross-sectional and longitudinal increase in tau-PET per unit increase in amyloid-PET when compared to that of non-carriers. This association of KL-VShet on tau-PET was stronger in Klotho mRNA-expressing brain regions mapped onto a gene expression atlas. KL-VShet was related to better memory functions in amyloid-positive participants and this association was mediated by lower tau-PET. Amyloid-PET levels did not differ between KL-VShet carriers versus non-carriers. Together, our findings provide evidence to suggest a protective role of KL-VShet against amyloid-related tau pathology and tau-related memory impairments in elderly humans at risk of AD dementia.

Download activity - last month

Export as CSVXMLJSON

Download activity - last 12 months

Export as JSONXMLCSV

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item